SCHEMBL3847438

SCHEMBL3847438

COc1ccccc1C1CCN(c2ncnc3ccc(-c4cnn(C(c5ccccc5)(c5ccccc5)c5ccccc5)c4)cc23)CC1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.53
ALDH1A1 P00352 4/20 0.50
CYP1A2 P05177 4/20 0.50
CYP3A4 P08684 4/20 0.50
CYP2C19 P33261 4/20 0.50
LMNA P02545 3/20 0.50
HIF1A Q16665 3/20 0.50
MEN1 O00255 2/20 0.50
TSHR P16473 2/20 0.50
KMT2A Q03164 2/20 0.50
CYP2D6 P10635 2/20 0.50
KDM4E B2RXH2 1/20 0.50
HPGD P15428 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CLK4 Q9HAZ1 3/20 0.49
USP2 O75604 2/20 0.49
MAPK1 P28482 2/20 0.49
TP53 P04637 1/20 0.49
NTSR1 P30989 15/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845834 0.87 CYP3A4 (0.47) ALDH1A1CYP1A2CYP3A4CYP2C19LMNA
SCHEMBL3846539 0.86 CYP3A4 (0.44) ALDH1A1CYP1A2CYP3A4CYP2C19LMNA
SCHEMBL3845891 0.81 ACHE (0.47) ALDH1A1CYP1A2CYP3A4CYP2C19LMNA
SCHEMBL3852801 0.80 HRH3 (0.44) ALDH1A1CYP1A2CYP3A4CYP2C19LMNA
SCHEMBL3845946 0.80 CYP1A2 (0.57) SLC2A1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL3846795 0.80 CYP1A2 (0.59) ALDH1A1CYP1A2CYP3A4CYP2C19LMNA
SCHEMBL3847535 0.79 CYP3A4 (0.43) ALDH1A1CYP1A2CYP3A4CYP2C19LMNA
SCHEMBL13874652 0.78 ALDH1A1 (0.57) SLC2A1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL3849227 0.77 CHRM4 (0.46) ALDH1A1CYP1A2CYP3A4CYP2C19LMNA
SCHEMBL3847121 0.77 MAPT (0.50) SLC2A1ALDH1A1CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed